Literature DB >> 9176707

A vision of cell death: insights into immune privilege.

T A Ferguson1, T S Griffith.   

Abstract

Immune privilege is a term applied to several organs that have a unique relationship with the immune response. These sites prohibit the spread of inflammation since even minor episodes can threaten organ integrity and function. The most prominent examples of these are the eye, brain and reproductive organs where immune responses either do not proceed, or proceed in a manner different from other areas. Once thought to be a passive process relying on physical barriers, immune privilege can now be viewed as an active process that utilizes multiple mechanisms to maintain organ function. Recently there has been a renewed interest in immune privilege when it was shown that two privileged sites (the eye and testes) constitutively express FasL, which functions by killing lymphoid cells that invade these areas. Here we will examine the role of FasL in immune privilege and discuss how this molecule interacts with other elements of the inflammatory response to maintain organ integrity in the face of potentially damaging immune reactions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176707     DOI: 10.1111/j.1600-065x.1997.tb00967.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  38 in total

Review 1.  Control of apoptosis of cardiovascular fibroblasts: a novel drug target.

Authors:  H Rupp; B Maisch
Journal:  Herz       Date:  1999-05       Impact factor: 1.443

Review 2.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 3.  Fugetaxis: active movement of leukocytes away from a chemokinetic agent.

Authors:  Fabrizio Vianello; Ivona T Olszak; Mark C Poznansky
Journal:  J Mol Med (Berl)       Date:  2005-09-03       Impact factor: 4.599

Review 4.  Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.

Authors:  Nancy Gordon; Eugenie S Kleinerman
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-08       Impact factor: 2.849

5.  Rabies virus ocular disease: T-cell-dependent protection is under the control of signaling by the p55 tumor necrosis factor alpha receptor, p55TNFR.

Authors:  S Camelo; J Castellanos; M Lafage; M Lafon
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 6.  Glucocorticoids and central nervous system inflammation.

Authors:  Klaus Dinkel; William O Ogle; Robert M Sapolsky
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 7.  Signals from dying cells: tolerance induction by the dendritic cell.

Authors:  Thomas A Ferguson; Hirotaka Kazama
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 8.  Angiogenesis in eye disease: immunity gained or immunity lost?

Authors:  Thomas A Ferguson; Rajendra S Apte
Journal:  Semin Immunopathol       Date:  2008-02-23       Impact factor: 9.623

9.  Quantitative evaluation of the corneal endothelium in the mouse after grafting.

Authors:  J Plskova; L Kuffova; M Filipec; V Holan; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

10.  Role of complement regulatory proteins in the survival of murine allo-transplanted Sertoli cells.

Authors:  Hak-Mo Lee; Byoung Chol Oh; Dong-Pyo Lim; Dong-Sup Lee; Jaejin Cho; Gene Lee; Jeong Ryul Lee
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.